Article
Magnetic resonance imaging criteria for prediction of isocitrate dehydrogenase (IDH) mutation status in patients with grade II-III astrocytoma and oligodendroglioma.
Clinical neurology and neurosurgery - 1 Aug 2021
Çelik Serkan, Öven Bala Başak, Demir Mustafa Kemal, Yılmaz Enis Çağatay, Kanan Duaa, Özdamarlar Umut, Emirzeoglu Levent, Yapıcıer Özlem, Kılıç Türker
Abstract excerpt
BACKGROUND: IDH mutation status is an important prognostic marker for glial tumors, which is detected immunohistochemically after surgery. Since this method is invasive, easy and noninvasive magnetic resonance imaging (MRI) methods have recently been used in predicting the IDH mutation status. However, there is currently no standard MRI technique to predict IDH mutation. We analyzed the value of conventional MRI...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.